For media inquiries, contact firstname.lastname@example.org.
Blue Note Therapeutics Enters Licensing Agreement with the University of Miami
The agreement allows Blue Note to develop and commercialize a prescription digital therapeutic for stress management in cancer patients.
Read more →
Do you have comments or inquiries about our products in development, partnering opportunities or career opportunities? Write to us here.
Note: if you are a study participant, please contact your study coordinator.